ArticleMaterials today. Bio2025
Temperature-independent and photocrosslinkable hydrolyzed GelMA with tunable mechanics for biofabrication.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A recent review on smart dressings for chronic wound management: from diagnosis to therapy.RSC advances · 2026Review
- Siloxane-Reinforced GelMA/Methacrylated Chitosan Hydrogels for DLP Printing.Gels (Basel, Switzerland) · 2026Article
- Bioadhesive Hydrogels for Tissue Repair: Design Strategies, Adhesion Mechanisms, and Emerging Applications.Molecules (Basel, Switzerland) · 2026Review
- Cutting-Edge Smart Hydrogel Platforms for Improved Wound Healing.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thermoresponsive and photo-crosslinkable hydrogels are highly desirable for biofabrication; however, conventional gelatin methacryloyl (GelMA) exhibited thermal gelation below 30 °C and high viscosity, restricting its compatibility with concentration-dependent tunability and lower critical solution temperature-type systems. To address these issues, hydrolyzed GelMA (hGelMA) was developed by subjecting GelMA to controlled enzymatic degradation, effectively eliminating thermal gelation while maintaining photo-crosslinkability and enabling broader control of the mechanical properties through concentration adjustment. The resulting hGelMA was characterized for viscosity, mechanical tunability, and compatibility with digital light processing bioprinting. Cell compatibility was evaluated, and the ability of hGelMA to integrate with thermoresponsive hydrogels, such as hydroxybutyl-methacrylated chitosan, was assessed to demonstrate its suitability for composite bioink systems. hGelMA showed significantly reduced viscosity, supported high-resolution digital light processing bioprinting across a wide stiffness range, and maintained excellent cell compatibility. In addition, its temperature-independent behavior facilitated its integration with thermoresponsive hydrogels exhibiting lower critical solution temperature (LCST) behavior, thereby broadening its potential for composite bioink systems. These findings indicate that hGelMA could serve as a practical and adaptable material for use in bioink formulations for tissue engineering and bioprinting applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.